The exosome research market is projected to reach USD 661 million by 2026 from USD 144 million in 2021, at a CAGR of 35.6% during the forecast period. Factors such as the rising funding for life sciences research, increasing interest in exosome-based procedures, and expanding translational medicine applications have offered lucrative opportunities to the market players.
Prominent players in the global exosome research market are Thermo Fisher Scientific (US), System Biosciences (US), Bio-Techne (US), Lonza (Switzerland), QIAGEN N.V. (Germany), NX PharmaGen (US), Miltenyi Biotec (US), AMS Biotechnology (US), NanoSomiX (US), Norgen Biotek Corp. (US), Novus Biologicals (US), BioVision Inc. (US), Pall Corporation (US), Exopharm Limited (Australia), and EverZom (France).
To know about the assumptions considered for the study download the pdf brochure
THERMO FISHER SCIENTIFIC (US) dominates the exosome research market. The company’s strong brand recognition and extensive product portfolio is its key strength. Thermo Fisher Scientific adopts organic and inorganic growth strategies to maintain its leading position in this market, such as acquisitions and expansions. For instance, in the past three years, the company expanded its presence by opening a new business center and biorepository—US Precision Medicine Science Center (PMSC) in Cambridge and a new state-of-the-art clinical services facility in South Korea. Such expansions help Thermo Fisher in strengthening its geographical presence. Its efforts to enhance its financial strategies have also helped it sustain its existing position within this market.
QIAGEN (GERMANY)-The company’s dominant position can be attributed to its strong brand image and robust product portfolio. QIAGEN has one of the highest profit margins of companies in life science research and diagnostics. The company’s profit margins have consistently remained above 50% between 2020 and 2019. The company has a strong geographic presence across the globe. It markets its products in over 100 countries in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. QIAGEN also offers excellent support and sales services.
BIO-TECHNE (US) is one of the prominent players in the global exosome research market. The company’s strong focus on a broad range of customers, technology-enabled solutions, investments in collaborations & partnerships, and comprehensive quality systems and processes contribute to the growth of the company’s market share.
Exosome Research Market by Product and services (Kits, Reagents, Instrument), Indication (Cancer, Infectious Diseases), Application (Biomarkers, Vaccines), Manufacturing Services (Stem cell, Dendritic cell-derived), End User - Global Forecast to 2026
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.SEND ME A FREE SAMPLE